Results 131 to 140 of about 7,946 (150)

Cognitive and antismoking effects of varenicline in patients with schizophrenia or schizoaffective disorder

Schizophrenia Research, 2009
Jean-Pierre Lindenmayer, Robert C Smith, Henry Sershen   +2 more
exaly  

Varenicline

Reactions Weekly, 2018
openaire   +1 more source

Varenicline Versus Bupropion SR or Placebo for Smoking Cessation: A Pooled Analysis

American Journal of Health Behavior, 2008
Mitchell Nides, Glover Elbert D
exaly  

Neuropsychiatric safety and efficacy of varenicline, bupropion, and nicotine patch in smokers with and without psychiatric disorders (EAGLES): a double-blind, randomised, placebo-controlled clinical trial

Lancet, The, 2016
Robert West, Robert Anthenelli, Neal Benowitz   +2 more
exaly  

Varenicline for opioid withdrawal in patients with chronic pain: A randomized, single-blinded, placebo controlled pilot trial

Addictive Behaviors, 2015
W Michael Hooten
exaly  

Varenicline Improves Mood and Cognition During Smoking Abstinence

Biological Psychiatry, 2009
Freda Patterson, Steven J Siegel, Ken Perkins   +2 more
exaly  

Population pharmacokinetic analysis of varenicline in adult smokers

British Journal of Clinical Pharmacology, 2009
Hélène Faessel
exaly  

Single-Dose Pharmacokinetics of Varenicline, a Selective Nicotinic Receptor Partial Agonist, in Healthy Smokers and Nonsmokers

Journal of Clinical Pharmacology, 2006
Hélène Faessel
exaly  

Vareniclin

2013
openaire   +1 more source

Varenicline

Reactions Weekly, 2019
openaire   +2 more sources